, medical device business is expected to be growth at an average rate of 8.5-10.0% per year. This growth will be supported by: (i) government policy, focused on promoting investment in the sector through the
1,921 million decreased by 7% compared to the previous year. It derived from: • Revenues from sales and services of medical device business for the year 2019 were Baht 1,798 million decreased by 3% in
(minute/s Postpaid Prepaid Blended VOU (GB/data s Postpaid Prepaid Blended Device Penetrat 4G‐handset Fixed Broadban FBB subscri FBB net add FBB ARPU ( 1H17 Snap For 1H17, AIS (excluding IC
% -2.4% Prepaid 113 92 86 -24% -6.5% Blended 138 118 112 -19% -5.1% VOU (GB/data sub/month) Postpaid 14.4 16.6 17.0 18% 2.3% Prepaid 10.3 11.1 13.8 34% 23% Blended 11.4 12.7 14.7 29% 16% Device Penetration
appropriate by Dhipaya Bodin as a joint venture. It will benefit potential shareholders in the medical device and distribution business. The current production and distribution line is Blood Line with a
305 296 280 271 264 Prepaid 213 201 190 169 163 Blended 226 215 205 186 181 VOU (GB/data sub/month) Postpaid 4.1 5.0 5.7 6.7 7.5 Prepaid 2.7 3.2 3.5 4.1 5.4 Blended 3.0 3.6 4.0 4.7 5.9 Device
. Customers were required to commit to a certain price plan to improve ARPU level through data and device bunding packages. Meanwhile, there were campaigns and offerings in prepaid segment at a minimal scale
lower network traffic with TOT and change in IC rate effective from Jan- 22. Device & SIM card sales reported Bt9,270mn, decreasing -4.3% YoY and -32% QoQ. QoQ drop was mainly from high seasonal sales of
4.8 Conditions for termination of agreement e.g. where the delegatee has not perform in accordance with the rules, where the performance is unsatisfactory or where there occurs financial problem. 4.9